Try our Advanced Search for more refined results
May 06, 2016
ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.
Case Number:
2:16-cv-02526
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 12, 2016
Impax Looks To Duck Endo's $100M Suit Over Drug Licensing
Generic-drug maker Impax Laboratories asked a New Jersey federal judge Monday to toss Endo Pharmaceuticals' $100 million lawsuit alleging it is refusing to negotiate royalty payments on a generic version of the painkiller Opana ER, saying a 2010 settlement allows royalty-free marketing and sale of the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login